May is Healthy Vision Month, a time to prioritize eye health and spread awareness about the importance of regular eye...
Blog Article
Welcome to University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Apr 30, 2024 | Blog Article, Uncategorized
Last week Leiters Health welcomed pharmacy students from the University of Colorado Skaggs School of Pharmacy and...
Leiters Health Announces American Society of Health-System Pharmacists (ASHP) Foundation Sponsorship
Apr 23, 2024 | Blog Article
Leiters Health is excited to announce that we are now a proud sponsor of the American Society of Health-System Pharmacists...
Enhanced Recovery After Surgery (ERAS) Protocols
Apr 18, 2024 | Blog Article
In recent years, many hospitals and health systems have been actively implementing Enhanced Recovery After Surgery (ERAS)...
Welsh, Carson, Anderson & Stowe Acquires Majority Stake in Leiters, A 503B Outsourced Pharmaceutical Compounding Industry Leader, in Partnership with Leading Health Systems
Nov 15, 2021 | Blog Article, News and Press Releases
Introducing IV Solutions: An innovative new offering coming soon from Leiters.
Sep 1, 2021 | Blog Article
As the healthcare landscape changes, so do the pressures on hospitals, surgery centers and healthcare providers. With...
Summa Health and Leiters Collaborate to Reduce Opioid Use.
Sep 1, 2021 | Blog Article
Leiters and Summa Health have collaborated for over two years on a compounded nerve block agent.
The partnership between Summa Health’s anesthesia and pharmacy departments and Leiters was published in a recent case study.
Are you in the LOOP?
Sep 1, 2021 | Blog Article
Leiters is pleased to announce that we have upgraded our Leiters Online Ordering Portal (LOOP) to provide you with an improved user experience and additional functionality. Our portal allows you direct access to place orders online quickly and easily, view your order status, track shipments, create ordering templates for commonly purchased products, view electronic documentation for controlled substances and much more!
Innovating to support your opioid reduction efforts and ERAS Protocols.
Sep 1, 2021 | Blog Article
This patent-pending combination sterile preparation consists of three non-opioid drugs in a ready-to-administer syringe: bupivacaine HCI, dexamethasone sodium phosphate, and epinephrine.